Middlefield, CT, United States of America

Mark T Meyering



Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 548(Granted Patents)


Location History:

  • Middlefield, CT (US) (1986 - 2005)
  • Middletown, CT (US) (2013)
  • Saint Paul, MN (US) (2018)

Company Filing History:


Years Active: 1986-2018

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mark T Meyering

Introduction

Mark T Meyering is an accomplished inventor based in Middlefield, Connecticut. With a remarkable portfolio of 14 patents, he has made significant contributions to the field of biotechnology. His innovative work primarily focuses on the development of novel materials and processes for nucleic acid isolation, amplification, and detection.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Nucleic Acid Binding Matrix." This patent describes a microporous membrane made from a highly electropositive hydrophilic material, which allows for the irreversible binding of nucleic acids. The membrane’s versatility enables it to be utilized in isolating, amplifying, and detecting nucleic acids, as well as detailing methods for its creation and utilization.

Another key patent is the "Process for Making a Three-Zone Microporous Membrane." This involves methods for manufacturing a reinforced, three-zone microporous membrane featuring various pore sizes, created from a single mother dope batch. The meticulous process includes control of dope temperatures and heating techniques to achieve the desired pore characteristics.

Career Highlights

Mark's career has been marked by his tenure at notable companies such as Cuno, Inc. and Amf Gmbh, where he contributed to the development of advanced filtration and membrane technologies. His extensive experience in the field of membrane technology has played a key role in shaping his patented inventions.

Collaborations

Throughout his career, Mark T Meyering has collaborated with esteemed colleagues, including Jack H Vining and C Thomas Badenhop. These collaborations have allowed him to combine expertise and innovate new solutions in the realm of biotechnology.

Conclusion

With a total of 14 patents to his name, Mark T Meyering stands as a prominent figure in the field of innovation in nucleic acid technologies. His latest patents not only demonstrate his inventive prowess but also contribute to advancements that could have significant implications for scientific research and application in various industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…